Xiaodong Luo

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Topics

Renal Cell Carcinoma

Computed Tomography

Top Venues

Statistics in medicine

Neurology and therapy

Pharmaceutical statistics

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Fredrik Nils Albach, Christian Geier, Christian Keicher, Maximilian G Posch, Stephan J Schreiber, Gerald Grütz, Levent Akyüz, Xiaodong Luo, Annaig Le-Halpere, Philippe Truffinet, Frank Wagner
Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis. Neurology and therapy (2024)
Xiaodong Luo, Yuan Sun, Zhixing Xu
A MCP-Mod approach to designing and analyzing survival trials with potential non-proportional hazards. Pharmaceutical statistics 21 (6) (2022)
Jin Jin, Marie-Karelle Riviere, Xiaodong Luo, Yingwen Dong
Bayesian methods for the analysis of early-phase oncology basket trials with information borrowing across cancer types. Statistics in medicine 39 (25) (2020)
Bo Huang, Lu Tian, Zachary Ryan McCaw, Xiaodong Luo, Enayet Talukder, Mace Rothenberg, Wanling Xie, Toni K Choueiri, Dae Hyun Kim, Lee-Jen Wei
Analysis of Response Data for Assessing Treatment Effects in Comparative Clinical Studies. Annals of internal medicine 173 (5) (2020)
Xiaodong Luo, Bo Huang, Hui Quan
Design and monitoring of survival trials based on restricted mean survival times. Clinical trials (London, England) 16 (6) (2019)
Xiaodong Luo, Xuezhou Mao, Xun Chen, Junshan Qiu, Steven Bai, Hui Quan
Design and monitoring of survival trials in complex scenarios. Statistics in medicine 38 (2) (2018)
Xiaodong Luo, Hong Tian, Surya Mohanty, Wei Yann Tsai
Rejoinder to "on the alternative hypotheses for the win ratio". Biometrics 75 (1) (2018)
Xiaodong Luo, Junshan Qiu, Steven Bai, Hong Tian
Weighted win loss approach for analyzing prioritized outcomes. Statistics in medicine 36 (15) (2017)